Electromed (ELMD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Sep, 2026Executive summary
Annual meeting scheduled for November 13, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by November 12, 2026.
Voting matters and shareholder proposals
Election of seven directors is proposed, with specific nominees listed.
Ratification of RSM US LLP as the independent registered public accounting firm is up for vote.
Advisory vote on executive compensation (say-on-pay) is included.
Approval of the Employee Stock Purchase Plan is proposed.
Proxies may vote on other business properly brought before the meeting.
Board of directors and corporate governance
Board size set at seven, with named nominees for election.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Electromed
- Virtual annual meeting to vote on directors, auditor, executive pay, and new stock purchase plan.ELMD
Proxy filing - Strong growth, high margins, and new clinical guidelines drive expansion in a $3B US market.ELMD
H.C. Wainwright 28th Annual Global Investment Conference - Record revenue, margin expansion, and robust cash flow highlight FY 2026 performance.ELMD
Q4 2026 - Record revenue and profit growth driven by strong homecare and hospital performance.ELMD
Q3 2026 - Strong growth, high margins, and clinical impact drive leadership in airway clearance technology.ELMD
Investor presentation - Strong growth, high margins, and clinical impact drive leadership in airway clearance technology.ELMD
Investor presentation - Strong growth, high margins, and clinical impact in the expanding airway clearance market.ELMD
Investor presentation - Record revenue and net income growth, higher margins, and strong cash position for FY 2024.ELMD
Q4 2024 - Record revenue, margin expansion, and strong cash flow highlight robust Q2 performance.ELMD
Q2 2025